摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dimethyl 1,2,4,5-tetrahydro-3-oxobenzocycloheptene-2,4-dicarboxylate | 24790-66-7

中文名称
——
中文别名
——
英文名称
dimethyl 1,2,4,5-tetrahydro-3-oxobenzocycloheptene-2,4-dicarboxylate
英文别名
dimethyl 3-oxo-1,2,4,5-tetrahydrobenzocycloheptene-2,4-dicarboxylate;Dimethyl 3-oxo-2,3,4,5-tetrahydro-1H-benzocycloheptene-2,4-dicarboxylate;dimethyl 3-oxo-1,2,4,5-tetrahydrobenzo[d]cycloheptene-2,4-dicarboxylate;dimethyl 7-oxo-6,7,8,9-tetrahydro-5H-benzo[7]annulene-6,8-dicarboxylate;Dimethyl 1,2-benzo-1-cyclohepten-5-one-4,6-dicarboxylate;dimethyl benzo[d]cycloheptenone-6,8-dicarboxylate;dimethyl 7-oxo-5,6,8,9-tetrahydrobenzo[7]annulene-6,8-dicarboxylate
dimethyl 1,2,4,5-tetrahydro-3-oxobenzo<d>cycloheptene-2,4-dicarboxylate化学式
CAS
24790-66-7
化学式
C15H16O5
mdl
——
分子量
276.289
InChiKey
AKTMCFLYKONPOD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    84-88 °C
  • 沸点:
    400.6±45.0 °C(Predicted)
  • 密度:
    1.223±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    69.7
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Bemcentinib. Tyrosine-protein kinase receptor UFO (Axl) inhibitor, Treatment of cancer
    摘要:
    Increased expression of Axl has been reported in various cancers including colon, esophageal, thyroid, breast, lung, liver and astrocytoma-glioblastoma. Cancer resistance to tyrosine kinase inhibitors and other chemotherapeutics has been correlated with aberrant expression of Axl. These findings support the development of Axl inhibitors in combination with targeted agents to tackle acquired resistance and high Axl levels. Bemcentinib (BGB-324, R-428) is an oral, potent and selective small-molecule inhibitor of Axl kinase in vitro with IC50 values in the low nanomolar range. In preclinical studies, bemcentinib demonstrated efficacy across multiple cancer models. It has also shown a favorable safety profile in clinical studies in cancer patients, and encouraging activity in acute myeloid leukemia (AML) and non-small cell lung cancer (NSCLC). Currently, there are phase II studies with bemcentinib ongoing in advanced NSCLC, triple-negative breast cancer, AML and myelodysplastic syndromes, and metastatic melanoma. Orphan drug designation was granted by the U.S. Food and Drug Administration for the treatment of AML.
    DOI:
    10.1358/dof.2018.043.09.2808543
  • 作为产物:
    参考文献:
    名称:
    AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER
    摘要:
    本发明旨在提供一种用于预防、治疗或管理患者的癌症,特别是转移性癌症的方法。该方法包括在给予一种或多种化疗药物的有效剂量的同时,给予一种Axl抑制剂的有效剂量。
    公开号:
    US20170042891A1
点击查看最新优质反应信息

文献信息

  • Palladium-Catalysed Isomerisation of 2-Vinylidenehydrofurans to 1,3-Dienes and Some Aspects of Their Reactivity
    作者:Abdelkader Ghobsi、Salih Hacini、Laurence Wavrin、Anouk Gaudel-Siri、Agnès Corbères、Cyril Nicolas、Damien Bonne、Jacques Viala、Jean Rodriguez
    DOI:10.1002/ejoc.200800517
    日期:2008.9
    The transformation of easily accessible 2-vinylidenehydrofurans into stable 1,3-dienes has been achieved by using catalytic amounts of palladium(0). These valuable compounds were then engaged in subsequent Diels-Alder reactions giving access to complex heterocyclic cores found in numerous natural products. A rationale for the regioselectivity of the Diels-Alder reactions with vinylfurans has been provided
    使用催化量的钯 (0) 已实现将容易获得的 2-亚乙烯基氢呋喃转化为稳定的 1,3-二烯。这些有价值的化合物随后参与了随后的 Diels-Alder 反应,从而获得了在众多天然产物中发现的复杂杂环核。DFT 计算提供了 Diels-Alder 反应与乙烯基呋喃的区域选择性的基本原理。
  • AMINOBENZOCYCLOHEPTENE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USES THEREOF IN THERAPY
    申请人:Tarnus-Rondeau Céline
    公开号:US20100069504A1
    公开(公告)日:2010-03-18
    A compound of the general formula (I) as an active principle for treating cancer, specifically tumors, in particular diseases involving inhibition of metalloproteases, such as Aminopeptidase-N. Pharmaceutical compositions comprising the compound of general formula (I). Methods of treatment using the compound of general formula (I).
    一种具有一般化学式(I)的化合物作为治疗癌症的活性成分,特别是肿瘤,特别是涉及金属蛋白酶抑制的疾病,如氨基肽酶-N。包括具有一般化学式(I)的化合物的药物组合物。使用一般化学式(I)的化合物进行治疗的方法。
  • New strategy to construct fused/bridged/spiro carbocyclic scaffolds based on the design of novel 6-C synthon precursor
    作者:Jia Liu、Xi Wang、Chang-Liang Sun、Bi-Jie Li、Zhang-Jie shi、Min Wang
    DOI:10.1039/c0ob00660b
    日期:——
    In this article we report a new strategy to build fused/spiro/bridged carbocyclic systems with a novel 6-C synthon from readily available diallyl diacetates through the sequential Pd-catalyzed double allyl alkylation and Diels–Alder annulation. Further exploration on the application of this strategy can construct useful complex scaffolds.
    在本文中,我们报告了一种新的策略,通过连续的钯催化双烯烃烷基化和Diels-Alder环加成,从易得的二烯丙基二酸酯构建带有新型6-C合成单元的融合/螺环/桥联碳环系统。对这一策略的进一步探索可以构建有用的复杂骨架。
  • C−C versus C−O Anionic Domino Cycloalkylation of Stabilized Carbanions: Facile One-Pot Stereoselective Preparation of Functionalized Bridged Bicycloalkanones and Cyclic Enol Ethers
    作者:Tania Lavoisier-Gallo、Emmanuelle Charonnet、Jean-Marc Pons、Michel Rajzman、Robert Faure、Jean Rodriguez
    DOI:10.1002/1521-3765(20010302)7:5<1056::aid-chem1056>3.0.co;2-d
    日期:2001.3.2
    cycloalkylation, to synthetically valuable monocyclic or fused polycyclic functionalized enol ethers of high synthetic value. Semiempirical calculations showed a small difference in energy and the late character of the transition states leading to cis and trans isomers of the corresponding fused polycyclic enol ethers. These results, although minimizing the influence of a destabilizing 1,3-interaction
    α,α'-双活化环状或无环酮经历化学选择性碱促进(K2CO3,DBU)一锅 CC 环烷基化,1,3- 和 1,4-二卤化物具有顺式固定构型。该反应产生高度官能化的双环 [3.2.1]octan-9-one 和双环 [4.2.1]nonan-9-one 衍生物,它们很容易通过高产率逆狄克曼裂解转化为七元和八元环. 从反式-1,4-二溴-2-丁烯开始,该转化受立体电子因素的控制,并通过化学和立体选择性的 CO 环烷基化,导致具有合成价值的单环或稠合多环官能化烯醇醚具有高合成价值。半经验计算显示能量的微小差异和导致相应稠合多环烯醇醚顺式和反式异构体的过渡态的后期特征。这些结果虽然最大限度地减少了不稳定的 1,3-相互作用对反应结果的影响,但在质量上与实验结果一致。
  • Quadruple Decker [3.3][3.3][3.3]Orthocyclophane Acetal—An Orthocyclophane Ladder
    作者:Shuntaro Mataka、Kouichiro Shigaki、Tsuyoshi Sawada、Yoshihara Mitoma、Masahiko Taniguchi、Thies Thiemann、Kazuya Ohga、Naoyoshi Egashira
    DOI:10.1002/(sici)1521-3773(19981002)37:18<2532::aid-anie2532>3.0.co;2-r
    日期:1998.10.2
    Through clever bridging of orthocyclophanes (in this case by acetalization), molecules such as 1 can be formed with four benzene rings in a stacked face-to-face arrangement. UV/Vis spectroscopic and electrochemical properties of 1 are governed by π-π through-space interactions within the molecule.
    通过邻桥环烷的灵巧桥接(在这种情况下为缩醛化反应),可以以面对面堆叠的方式形成带有四个苯环的分子(如1)。1的UV / Vis光谱和电化学性质受分子内π-π贯穿空间相互作用的支配。
查看更多

同类化合物

2,9-二(2-苯乙基)蒽并[2,1,9-DEF:6,5,10-D’E’F’]二异喹啉-1,3,8,10(2H,9H)-四酮 (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-盐酸沙丁胺醇 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3,3''-双([[1,1''-联苯]-4-基)-[1,1''-联萘]-2,2''-二醇 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3S,3aR)-2-(3-氯-4-氰基苯基)-3-环戊基-3,3a,4,5-四氢-2H-苯并[g]吲唑-7-羧酸 (3R,3’’R,4S,4’’S,11bS,11’’bS)-(+)-4,4’’-二叔丁基-4,4’’,5,5’’-四氢-3,3’’-联-3H-二萘酚[2,1-c:1’’,2’’-e]膦(S)-BINAPINE (3-三苯基甲氨基甲基)吡啶 (3-[(E)-1-氰基-2-乙氧基-2-hydroxyethenyl]-1-氧代-1H-茚-2-甲酰胺) (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-硝基苯基)磷酸三酰胺 (2-氯-6-羟基苯基)硼酸 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1α,1'R,4β)-4-甲氧基-5''-甲基-6'-[5-(1-丙炔基-1)-3-吡啶基]双螺[环己烷-1,2'-[2H]indene (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1R,1′R,2S,2′S)-2,2′-二叔丁基-2,3,2′,3′-四氢-1H,1′H-(1,1′)二异磷哚